Search research articles
Contact Us
Filters
Showing results (191-200 of 332) with videos related to
Page
of 34
Sort By:
Plos One
|
March 23, 2011
Carcinoma-derived interleukin-8 disorients dendritic cell migration without impairing T-cell stimulation
Carlos Alfaro, Natalia Suárez, Ivan Martínez-Forero, et al.
Plos One
|
June 13, 2015
B7-H3 Promotes Pathogenesis of Autoimmune Disease and Inflammation by Regulating the Activity of Different T Cell Subsets
Liqun Luo, Gefeng Zhu, Haiying Xu, et al.
Journal for Immunotherapy of Cancer
|
April 20, 2019
The clinical application of cancer immunotherapy based on naturally circulating dendritic cells
Kalijn F Bol, Gerty Schreibelt, Katrin Rabold, et al.
The Journal of Pathology
|
September 28, 2022
The association between the tumor immune microenvironments and clinical outcome in low-grade, early-stage endometrial cancer patients
Álvaro López-Janeiro, María Villalba-Esparza, María Emilia Brizzi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 16, 2004
Phase I trial of intratumoral injection of an adenovirus encoding interleukin-12 for advanced digestive tumors
Bruno Sangro, Guillermo Mazzolini, Juan Ruiz, et al.
Plos One
|
December 30, 2011
Dendritic cells take up and present antigens from viable and apoptotic polymorphonuclear leukocytes
Carlos Alfaro, Natalia Suarez, Carmen Oñate, et al.
Theranostics
|
January 29, 2026
Autocrine activity of engineered IL-33 mRNA enhances adoptive T-cell therapy for peritoneal carcinomatosis and synergizes with IL-12 mRNA
Leire Arrizabalaga, Claudia Augusta Di Trani, Celia Gomar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 14, 2013
Combined immunostimulatory monoclonal antibodies extend survival in an aggressive transgenic hepatocellular carcinoma mouse model
Aizea Morales-Kastresana, Miguel F Sanmamed, Inmaculada Rodriguez, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 27, 2020
Quantitative and qualitative impairments in dendritic cell subsets of patients with ovarian or prostate cancer
Beatris Mastelic-Gavillet, Apostolos Sarivalasis, Leyder Elena Lozano, et al.
International Journal of Cancer
|
September 21, 2010
Synergistic effects of CTLA-4 blockade with tremelimumab and elimination of regulatory T lymphocytes in vitro and in vivo
Natalia Suarez, Carlos Alfaro, Juan Dubrot, et al.
Page
of 34
Search research articles
Search
Showing results (191-200 of 332) with videos related to
Sort By:
Page
of 34
Plos One
|
March 23, 2011
Carcinoma-derived interleukin-8 disorients dendritic cell migration without impairing T-cell stimulation
Carlos Alfaro, Natalia Suárez, Ivan Martínez-Forero, et al.
Plos One
|
June 13, 2015
B7-H3 Promotes Pathogenesis of Autoimmune Disease and Inflammation by Regulating the Activity of Different T Cell Subsets
Liqun Luo, Gefeng Zhu, Haiying Xu, et al.
Journal for Immunotherapy of Cancer
|
April 20, 2019
The clinical application of cancer immunotherapy based on naturally circulating dendritic cells
Kalijn F Bol, Gerty Schreibelt, Katrin Rabold, et al.
The Journal of Pathology
|
September 28, 2022
The association between the tumor immune microenvironments and clinical outcome in low-grade, early-stage endometrial cancer patients
Álvaro López-Janeiro, María Villalba-Esparza, María Emilia Brizzi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 16, 2004
Phase I trial of intratumoral injection of an adenovirus encoding interleukin-12 for advanced digestive tumors
Bruno Sangro, Guillermo Mazzolini, Juan Ruiz, et al.
Plos One
|
December 30, 2011
Dendritic cells take up and present antigens from viable and apoptotic polymorphonuclear leukocytes
Carlos Alfaro, Natalia Suarez, Carmen Oñate, et al.
Theranostics
|
January 29, 2026
Autocrine activity of engineered IL-33 mRNA enhances adoptive T-cell therapy for peritoneal carcinomatosis and synergizes with IL-12 mRNA
Leire Arrizabalaga, Claudia Augusta Di Trani, Celia Gomar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 14, 2013
Combined immunostimulatory monoclonal antibodies extend survival in an aggressive transgenic hepatocellular carcinoma mouse model
Aizea Morales-Kastresana, Miguel F Sanmamed, Inmaculada Rodriguez, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 27, 2020
Quantitative and qualitative impairments in dendritic cell subsets of patients with ovarian or prostate cancer
Beatris Mastelic-Gavillet, Apostolos Sarivalasis, Leyder Elena Lozano, et al.
International Journal of Cancer
|
September 21, 2010
Synergistic effects of CTLA-4 blockade with tremelimumab and elimination of regulatory T lymphocytes in vitro and in vivo
Natalia Suarez, Carlos Alfaro, Juan Dubrot, et al.
Page
of 34